Sellas Life Sciences Group ISLS
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 30 institutions reported holding Sellas Life Sciences Group I (SLS) in their 13F filings, unchanged from Q1 2024. 9 opened new positions and 9 sold out. The largest holders were Vanguard Group Inc. ($2.1M), Geode Capital Management, LLC ($615K) and BlackRock Inc. ($512K). 2 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Sellas Life Sciences Group I
- CUSIP
- 81642T209
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $580K |
| Exits | 9 | $5.0M |
All 13F filers, Q1 2024 → Q2 2024: 1,286,994 shares bought and 4,944,278 shares sold, net −3,657,284 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 30 holders
| Vanguard Group Inc. | 0.00% | Add +18.1% | 1,786,334 | $2.1M |
| Geode Capital Management, LLC | 0.00% | Add +89.3% | 517,008 | $615K |
| BlackRock Inc. | 0.00% | Add +54.7% | 430,368 | $512K |
| Opus Capital Group, LLC | 0.04% | Add +10.2% | 221,000 | $263K |
| Equitable Holdings, Inc. | 0.00% | Add +5.0% | 210,000 | $250K |
| Diametric Capital, LP | 0.10% | New | 153,019 | $182K |
| Millennium Management | 0.00% | New | 150,448 | $179K |
| State Street Corp. | 0.00% | Add +38.0% | 134,029 | $159K |
| Northern Trust Corp. | 0.00% | Add +13.7% | 100,843 | $120K |
| Virtu Financial LLC | 0.01% | Add +61.9% | 63,843 | $76K |
| Prelude Capital Management, LLC | 0.01% | New | 55,726 | $66K |
| LPL Financial LLC | 0.00% | New | 51,894 | $62K |
| Mariner, LLC | 0.00% | Add +77.9% | 44,929 | $53K |
| Renaissance Technologies | 0.00% | New | 32,446 | $39K |
| Jane Street Group, LLC | 0.00% | New | 27,994 | $33K |
| Independent Financial Group, LLC | 0.00% | Add +14.8% | 23,250 | $28K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 16,238 | $19K |
| Commonwealth Equity Services, LLC | 0.00% | Add +10.7% | 15,554 | $19K |
| Wedbush Securities Inc. | 0.00% | New | 15,000 | $18K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -34.2% | 13,631 | $16K |
| Nemes Rush Group LLC | 0.00% | No change | 10,000 | $12K |
| Morgan Stanley | 0.00% | Add +132.2% | 3,297 | $4K |
| Osaic Holdings, Inc. | 0.00% | No change | 1,660 | $2K |
| Royal Bank of Canada | 0.00% | Add +200.0% | 669 | $1K |
| Bank of America Corp. | 0.00% | New | 577 | $687 |
| Jones Financial Companies LLLP | 0.00% | New | 374 | $445 |
| Allworth Financial LP | 0.00% | No change | 150 | $167 |
| Janiczek Wealth Management, LLC | 0.00% | No change | 11 | $14 |
| Parkside Financial Bank & Trust | 0.00% | No change | 2 | $3 |
| Qube Research & Technologies Ltd | 0.00% | No change | 2 | $2 |
"% of holder's portfolio" is SLS's weight in each manager's 13F, not the share of Sellas Life Sciences Group I the manager owns.